Sustained antigen release polyanhydride-based vaccine platform for immunization against bovine brucellosis

Development of a protein antigen based pneumococcal vaccine utilizing a polyanhydride nanoparticle delivery platform

Vaccines and Vaccine Candidates against Brucellosis

Brucella is a facultative intracellular pathogen, and brucellosis is commonest zoonotic disease worldwide. Brucella species, isolated from domestic animals, are important pathogen for humans. Annually, more than 500,000 new cases of brucellosis are reported, and this figure is an underestimate due to extended under-reporting cases in several endemic countries. Brucella has a variety of virulenc...

Single Dose Tetanus Vaccine Based on Polyanhydride Microspheres

[Complex immunization of animals against anthrax and brucellosis].

A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis

Objective(s): Mycobacterium tuberculosis (M. tuberculosis), an intracellular pathogen, causes 1.5 million deaths globally. Bacilli Calmette-Guérin (BCG) is commonly administered to protect people against M. tuberculosis infection; however, there are some obstacles with this first-generation vaccine. DNA vaccines, the third generation vaccines, can induce cellular immun...